Special

Bioprocessing

Hot topics in bioprocessing

As recently reported NK stem cells could provide a way to make CAR cell therapies cheaper because they do not need to be derived from individual patients. New drug formats such as cell & gene therapies, live microbial therapies, conjugates of or engineered antibodies are filling clincical pipelines, new and cost-effective processes are needed to make them a business case. Contract manufacturers that have all the capacities in-house to develop a biologic/advanced therapy GMP compliantly from preclinical stage to the filled & finished product have good chances in the emerging new markets.

Present your expertise in the journal of the official media partner

Drug developers, CDMOs and experts will have the opportunity to present their latest research, products, processes, and equipment in this special. European Biotechnology Magazine goes out to decision makers throughout the entire European Life Sciences sector. Take advantage of to the journal’s highly relevant readership and grab this opportunity to target your audience!

Topics to be covered

Services & equipment: cell line selection, process development & upscaling, process monitoring, QbD, single use equipment, media development, cell culture, glycoengineering, conjugation, formulation, fill & finish, DSP, continous processing, ex vivo genetic engineering, TCR engineering, IgG-like bispecifics, AAV and lentiviral vector technology, plasmid engineering, modular UPS and DSP, antibody engineering, purification, polishing.

NEW Publication Date: 09-04-2020

Booking Deadline: 27-03-2020

Marketing Contacts 

Andreas Macht
Tel: +49-30-264921-54
a.macht(at)biocom.de

Oliver Schnell
Tel: +49-30-264921-45
o.schnell(at)biocom.de

Editorial Contact

Thomas Gabrielczyk
Tel: +49-30-264921-50
t.gabrielczyk(at)biocom.de